To assess the capability of 18 F-2-tert-butyl-4-chloro-5-{6-[2-(2-fluoroethoxy)-ethoxy]-pyridin-3-ylmethoxy}-2H-pyridazin-3-one ( 18 F-BCPP-EF), a novel positron emission tomography (PET) probe for mitochondrial complex I (MC-I) activity, as a specific marker of ischemia-induced neuronal death without being disturbed by inflammation, translational research was conducted using an animal PET in ischemic brains of Cynomolgus monkeys (Macaca fascicularis). Focal ischemia was induced by the right middle cerebral artery occlusion for 3 hours, then PET scans were conducted at Day-7 with 15 O-gases for regional cerebral blood flow (rCBF) and regional cerebral metabolism of oxygen (rCMRO 2 ), and 18 F-BCPP-EF for MC-I with arterial blood sampling. On Day-8, the additional PET scans conducted with 11 C-flumazenil ( 11 C-FMZ) for central-type benzodiazepine receptors, 11 C-PBR28 for translocator protein, and 18 F-fluoro-2-deoxy-D-glucose ( 18 F-FDG) for regional cerebral metabolic rate of glucose (rCMRglc). The total distribution volume (V T ) values of 18 F-BCPP-EF showed the significant reduction in MC-I activity in the damaged area at Day-7. When correlated with rCBF and rCMRO 2 , the V T values of 18 F-BCPP-EF provided better correlation with rCMRO 2 than with rCBF. In the inflammatory regions (region of interest, ROI PBR ) of the ischemic hemisphere detected with 11 C-PBR28, higher 18 F-FDG uptake and lower V T of 18 F-BCPP-EF, 11 C-FMZ, and rCMRO 2 than those in normal contralateral hemisphere were observed. These results strongly suggested that 18 F-BCPP-EF could discriminate the neuronal damaged areas with neuroinflammation, where 18 F-FDG could not owing to its high uptake into the activated microglia.
INTRODUCTION
The mitochondrial respiratory chain (complexes I to V) is the major site of ATP production in eukaryotes. This organelle not only generates ATP, but also has an important role in the center of the apoptotic signaling pathway. 1 Among these five complexes, mitochondrial complex I (MC-I; NADH-ubiquinone oxidoreductase, EC 1.6.5.3) is the first enzyme of the respiratory electron transport chain. MC-I takes two electrons from NADH and transfers them to ubiquinone in the inner-mitochondrial membrane. Mitochondrial complex I uses the energy released from this process to move four protons across the membrane, creating charge separation across the membrane.
Mitochondrial dysfunction contributes to the pathophysiology of acute neurologic disorders and neurodegenerative diseases. 2 Mitochondria are considered the main intracellular source of reactive oxygen species (ROS) in cells and also the main target of ROS-mediated damage. Ischemia may cause mitochondrial alterations that would favor ROS production when the oxygen concentration is reestablished by reperfusion. 3 We showed that, immediately after reperfusion from the middle cerebral artery (MCA) occlusion (MCAO) for 3 hours (3-hour MCAO), postischemic hyperperfusion was observed in the neocortical area of monkey brain. 4, 5 When ischemic tissue is reoxygenated, electron transport through the respiratory chain is impaired because of depletion of ADP during ischemia, and this leads to a burst of ROS generation during the first minutes of reoxygenation. 3 To image MC-I function in the living brain using positron emission tomography (PET), we recently synthesized several novel PET probes, 6 and confirmed that 18 F-2-tert-butyl-4-chloro-5-{6-[2-(2-fluoroethoxy)-ethoxy]-pyridin-3-ylmethoxy}-2H-pyridazin-3-one ( 18 F-BCPP-EF) was most preferable for MC-I imaging in the living brain of rat 6, 7 and monkey. 8 Since whole-body PET imaging of rat indicated relatively high uptake and long retention in the brain, 6, 7 we hypothesized that PET probes for MC-I could be applicable for the imaging of neuronal damage in living brain. It was suggesting that 18 F-BCPP-EF could be useful to detect ischemic neuronal damage at the subacute phase 7 days after ischemic insult (Day-7), 7 at which time unexpectedly higher 18 F-fluoro-2-deoxy-Dglucose (FDG) uptake was observed in the damaged area than in the contralateral intact area. 9, 10 The FDG-PET is a well-established technique for quantitative imaging of the regional cerebral metabolic rate of glucose (rCMRglc) in living brain, which is based on the assumption that rCMRglc reflects energy metabolism via oxidative phosphorylation. However, the unexpectedly high uptake of 18 F-FDG in ischemia-damaged areas suggested that 18 F-FDG was taken up into not only normal tissues but also inflammatory regions with microglial activation. 9, 10 Since recent PET research has indicated that neurodegenerative disorders showed neuroinflammation with microglial activation, 11 PET probes to image MC-I activity would be favorable for more accurate assessment of neurodegenerative damage using PET.
The present study aimed to validate 18 F-BCPP-EF, a novel PET probe for MC-I activity, as a specific marker of ischemia-induced neuronal death without being disturbed by inflammation. The binding properties of 18 F-BCPP-EF were assessed in an ischemic brain model of living monkey using high-resolution PET, and its cerebral uptake was compared with the regional cerebral blood flow (rCBF), regional cerebral metabolism of oxygen (rCMRO 2 ) measured with 15 O-gases, 11 C-flumazenil ( 11 C-FMZ) binding to the central-type benzodiazepine receptor (CBR), 11 C-PBR28 binding to the translocator protein, and regional cerebral blood flow (rCMRglc) measured with 18 F-FDG at Day-7/8 after 3-hour MCAO ischemic insult in the monkey brain.
MATERIALS AND METHODS

Animals and Drugs
Animals were maintained and handled in accordance with the recommendations of the US National Institutes of Health and the guidelines of the Central Research Laboratory, Hamamatsu Photonics. The following experiments were approved by the Ethical Committee of the Central Research Laboratory, Hamamatsu Photonics. Seven male Cynomolgus monkeys (Macaca fascicularis) at the age between 4.5 and 5.3 years old with body weights ranging from 4.5 to 5.8 kg were used for the PET measurements. Magnetic resonance (MR) images (MRIs) of the monkeys were obtained with a 3.0-T MR imager (Signa Excite HDxt 3.0T; GE Healthcare Japan, Tokyo, Japan) using a 3D-Spoiled Gradient Echo sequence (176 slices with a 256 Â 256 image matrix, slice thickness/spacing of 1.4/0.7 mm, echo time: 3.4 to 3.6 ms, repetition time: 7.7 to 8.0 ms, inversion time: 400 ms, and flip angle, 151) under pentobarbital anesthesia. We could not conduct MR imaging after ischemic insult because our MRI system was located outside the radiation regulated area. Japanese low for the radiation safety regulation did not allow us to bring out the animals injected even positron emitters with short half-lives from radiation regulated area.
Isoflurane and pancronium were purchased from Dainippon Pharmaceutical (Osaka, Japan) and Sankyo Co. Ltd. (Tokyo, Japan), respectively. Rabbit anti-Iba1 polyclonal antibody was from Wako Pure Chemical Industry (Osaka, Japan). Mouse anti-NeuN monoclonal antibody and EnVision were obtained from Millipore (Billerica, MA, USA) and DAKO (Carpinteria, CA, USA), respectively. Precursors of 18 F-BCPP-EF, 11 C-FMZ, and 11 C-PBR28, and their corresponding cold compounds, were purchased from NARD Institute (Amagasaki, Japan). Mannose triflate and Kryptofix222 (K[2,2,2]) were obtained from ABX (Radeberg, Germany) and Merck (Darmstadt, Germany), respectively.
Positron Emission Tomography Ligand Syntheses
Positron-emitting carbon-11 ( 11 C), oxygen-15 ( 15 O), and fluorine-18 ( 18 F) were produced by 14 N(p, a) 11 C, 14 N(d, n) 15 O, and 18 O(p, n) 18 F nuclear reactions, respectively, using a cyclotron (HM-18; Sumitomo Heavy Industry, Tokyo, Japan) at Hamamatsu Photonics PET Center. Labeled compounds were synthesized using a modified CUPID system (Sumitomo Heavy Industries, Ltd., Tokyo, Japan). HPLC analyses of labeled compounds were performed on a GL-7400 low-pressure gradient HPLC system (GL Sciences, Inc., Tokyo, Japan) with a radioactivity detector (RLC-700; Hitachi Aloka Medical, Inc., Tokyo, Japan). 11 C-PBR28 for translocator protein imaging was labeled by 11 C-methylation of its O-desmethyl precursor with 11 C-methyl iodide. 12 Radiochemical purity was 499%, and specific radioactivity was 135.8 ± 38.6 GBq/mmol. 11 C-FMZ for CBR was labeled by 11 C-methylation of its N-desmethyl precursor with 11 C-methyl iodide. 13 Radiochemical purity was 499%, and specific radioactivity was 70.0 ± 51.2 GBq/mmol. The 18 F-BCPP-EF was radiolabeled by nucleophilic 18 F-fluorination of its corresponding precursor as reported previously. 6 Radiochemical purity was 499%, and specific radioactivity was 139.6 ± 37.0 GBq/mmol. 18 F-fluoro-2-deoxy-D-glucose was produced by nucleophilic 18 F-fluorination of mannose triflate after basic hydrolysis of 2-18 F-fluoro-1,3,4,6-tetra-O-acetyl-d-glucose according to a method described previously. 14 
Positron Emission Tomography Analysis in Monkey Brain
After overnight fasting, monkeys were tracheostomized, immobilized with 0.05 mg/kg pancronium bromide intramuscularly every 2 hours, and artificially ventilated. Anesthesia was continued with 0.8% isoflurane in a N 2 O/O 2 /N 2 (1:1:1) gas mixture during the entire experiment. After a transmission scan for 30 minutes using a 68 Ge-68 Ga rotation rod source, emission scanning with 18 F-FDG was conducted for 60 minutes, and scans with 11 C-BPR28 and 18 F-BCPP-EF were performed for 91 minutes after injection using a high-resolution animal PET scanner (SHR-7700; Hamamatsu Photonics, Hamamatsu, Japan). 15 The PET data obtained were reconstructed by the filtered back projection method with a Hanning filter of 4.5 mm full width at half maximum and attenuation correction using the transmission scan data. Individual PET and MRI images were coregistered. Volumes of interest in brain regions were drawn manually on the MRI referring regional information from BrainMaps.org, 16 and volumes of interest of MRI were superimposed on the coregistered PET images to measure the time-activity curves (TACs) of each PET probe for kinetic analyses. These processes were performed using the PMOD software (PMOD Technologies Ltd., Zurich, Switzerland).
For quantitative analysis of 18 F-BCPP-EF, PET scans were conducted with arterial blood sampling as reported previously. 8 Arterial blood samples were obtained every 8 seconds up to 64 seconds, followed by 90, 150 seconds, then 4, 6, 10, 20, 30, 45, 60, and 90 minutes after tracer injection, and these blood samples were centrifuged to separate plasma, weighed, and their radioactivity was measured. For metabolite analysis, methanol was added to some plasma samples (sample/methanol ¼ 1/1) obtained at 16, 40, 64 seconds, 6, 10, 30, and 45 minutes after the injection, followed by centrifugation. The obtained supernatants were developed using thin layer chromatography plates (AL SIL G/UV, Whatman, Kent, UK) with a mobile phase of ethyl acetate. The ratio of unmetabolized fraction was determined using a phosphoimaging plate (FLA-7000; Fuji Film, Tokyo, Japan). The input function of unmetabolized 18 F-BCPP-EF was calculated using the data obtained by correction of the ratio of the unmetabolized fraction to total radioactivity, which was used as the arterial input function.
As confirmed in our previous study, 8 kinetic analysis of 18 F-BCPP-EF was performed by 2-TC analysis, [17] [18] [19] which was performed using the PMOD software (PMOD Technologies Ltd.). The unknown rate constants (K 1 , k 2 , k 3 , and k 4 ) were calculated to fit the measured tissue radioactivity curve (C meas ) in each region of interest (ROI) using the input function, which was the radioactivity curve of the metabolite-corrected arterial plasma. The total distribution volume (V T ) was calculated by
The quantitative analyses of 11 C-FMZ and 11 C-PBR28 were performed by Logan graphical plot analysis 19 using the PMOD software (PMOD Technologies Ltd.). As an input function, the TAC in the cerebellum or pons was applied instead of the TAC of metabolite-corrected plasma.
Assessments of rCBF, rCMRO 2 , regional oxygen extraction fraction, and regional cerebral blood volume were conducted using the steady-state 15 O-gas inhalation method, 4, 5 with the successive inhalation of trace amounts of 15 O-CO 2 , 15 O-O 2 , and 15 O-CO. The mean values of radioactivity of whole blood and plasma were used for parametric image generation of rCBF, rCMRO 2 , regional oxygen extraction fraction, and regional cerebral blood volume. 20, 21 The CBV correction was performed for rCBF, rCMRO 2 , and regional oxygen extraction fraction measurements.
During PET measurement with 18 F-FDG for 60 minutes, 16 of arterial blood samples were withdrawn for arterial radioactivity measurements. The blood samples obtained at 45 and 60 minutes after injection were also analyzed for blood glucose levels with STAT PROFILE CCX (Nova Biomedical, Waltham, MA, USA). Positron emission tomography images from 40 to 60 minutes after 18 F-FDG injection were used to calculate rCMRglc by an autoradiographic method with an operational equation 22 and parameters with lumped constant of 0.56. 23 
Brain Ischemic Model of Monkey
Monkeys were tracheostomized, immobilized with 0.05 mg/kg pancronium bromide intramuscularly every 2 hours, and artificially ventilated (Cato, Drager, Germany). Anesthesia was continued with 0.8% isoflurane in a N 2 O/O 2 /N 2 (1:1:1) gas mixture during the entire experiment. The mean arterial blood pressure, heart rate, rectal temperature, arterial PO 2 and PCO 2 , and pH were continuously or regularly monitored. During the experiments, the animal's body temperature was maintained within normal limits with heating blankets. The right MCA was occluded with two microvascular clips via a transorbital approach for 3 hours, and then the clips were removed from the MCA for reperfusion. 4, 5 Monkeys were allowed to awaken after the scans, and they were subjected to PET measurements with 15 O-gases and 18 F-BCPP-EF 7 days (Day-7) after 3-hour MCAO ischemic insult. In addition, they were also measured with 11 C-FMZ, 11 C-PBR28, and 18 F-FDG at Day-8. Regions of interest (ROIs) of inflammatory regions at Day-7 (ROI PBR ), defined as areas with 420% increase in 11 C-PBR28 binding in the ipsilateral relative to the contralateral hemisphere, were placed on each quantitative image of rCMRO 2 , 11 C-FMZ, 18 F-FDG, rCMRglc, and 18 F-BCPP-EF. Furthermore, ROIs of infarct regions at Day-7 (ROI Infarct ), defined as areas with o40% decrease in rCMRO 2 in the ipsilateral relative to the contralateral hemisphere as previously reported, 24 were placed on each Imaging impaired MC-I in ischemic monkey brain H Tsukada et al quantitative image. The average ROI PBR and ROI Infarct were created from seven animals, and drown on MRI.
Immunohistochemical Assessment
Immunohistochemical assessments were performed with brains sampled at Day-7 after ischemic insults using rabbit anti-Iba1 polyclonal antibody and mouse anti-NeuN monoclonal antibody as reported previously. 5, 9 Brains were perfused transcardially with saline, then 4% paraformaldehyde in 0.1 mol/L sodium phosphate (pH 7.4) under anesthesia with overdose sodium pentobarbital. The brains were subsequently removed and postfixed overnight at 41C in 4% paraformaldehyde, then rapidly frozen in dry ice powder and sliced into 20-mm-thick coronal sections with a cryostat. The sections were mounted on slide glass, and incubated in phosphate buffer saline containing 0.1% Triton X-100 containing 5% normal goat serum for 30 minutesutes and reacted with primary antibodies at 41C overnight with rabbit anti-Iba1 polyclonal antibody (1:1,000; Wako Pure Chemical Industry, Tokyo, Japan), or mouse anti-NeuN monoclonal antibody (1:500; Millipore). The slides were then washed in phosphate buffer saline containing 0.1% Triton X-100 and incubated with EnVision plus reagents for rabbit or mouse (DAKO) for 30 minutes at room temperature. The sections were treated with 0.02% 3,3 0 -diaminobenzidine and 0.006% H 2 O 2 in 50 mmol/L Tris-HCl buffer (pH 7.6). The slides were finally counterstained with hematoxylin. The brain slides were scanned with NanoZoomer (Hamamatsu Photonics).
Statistical Analysis
Results are expressed as means ± s.d. Comparisons between conditions were performed using the paired, two-tailed Student's t-test. A probability level of o5% (Po0.05) was considered to indicate statistical significance.
RESULTS
Aided by individual monkey MRI ( Figure 1A) , several ROIs were set on PET images of the brain of normal animals to obtain the TACs of 18 F-BCPP-EF in each region ( Figure 1B, upper panel) . The TAC of 18 F-BCPP-EF in normal animals peaked at ca. 10 minutes after injection, except for the occipital cortex (peak time ¼ ca. 30 minutes), followed by gradual elimination with time ( Figure 2A) . The uptake levels at 20 minutes after injection were the highest in the temporal cortex and the striatum, intermediate in the frontal cortex, and the lowest in the occipital cortex, the hippocampus, and the cerebellum in the normal brain (Figure 2A) .
The kinetics and metabolic rate of 18 F-BCPP-EF in the plasma were very rapid; only ca. 6% of nonmetabolized parent compound was detected 90 minutes after the injection (insets of Figures 2A  and 2B ). Although the chemical species of metabolites have not yet been determined in plasma, they were very polar metabolites unable to enter the brain through the blood-brain barrier. With rapid metabolism of 18 F-BCPP-EF, no significant radioactivity accumulation was observed in the skull of monkey, suggesting the minimal defluorination metabolism of 18 F-BCPP-EF in plasma and brain tissue ( Figure 1B) .
As reported previously, 4,5 MCAO of the monkey brain for 3 hours acutely decreased rCBF and rCMRO 2 mainly in the striatum, which was the focal area for the supply of blood by the MCA, in the present study (data not shown). At Day-7 after 3hour MCAO ischemic insult, lower rCMRO 2 was detected not only in the striatum, but also in the cortex ( Figures 1D and 3B ), suggesting the induction of ischemic damage including reperfusion injury in the monkey brain. Our previous results showed that, immediately after reperfusion, postischemic hyperperfusion was observed in the neocortical area of monkey brain. 4, 5 In these hyperperfused areas, decreased rCMRO 2 was observed thereafter. In contrast, rCBF in the ischemia-damaged area indicated almost the same levels as in the intact area ( Figures 1C and 3A) .
In the monkey brain after 3-hour MCAO ischemic insult, the TAC of 18 F-BCPP-EF also provided a similar TAC pattern as well as uptake levels in the intact side of the brain, showing a peak 10 to 30 minutes after the injection and the uptake levels being the highest in the temporal cortex and the striatum, intermediate in the frontal cortex, and the lowest in the occipital cortex, the hippocampus, and the cerebellum ( Figure 2B) . In contrast, the TAC in the striatum, and frontal and temporal cortices of the right ischemic hemisphere revealed significantly lower levels than those in the intact hemisphere ( Figure 2B ). As shown in Figure 1B , the parametric images of V T of 18 F-BCPP-EF were created by 2-TC analysis using the metabolite-corrected plasma input (Figure 2 ), indicating the reduced binding of 18 F-BCPP-EF to MC-I in the damaged brain area of Day-7 after 3 hour MCAO ischemic insult compared with that in the insult area ( Figure 3C ).
On the PET images of 18 F-BCPP-EF ( Figure 1B , lower panel), rCBF ( Figure 1C ), and rCMRO 2 ( Figure 1D ) measured at Day-7 after 3hour MCAO ischemic insult, the same ROIs, determined with the aid of MRI ( Figure 1A) , were set on these PET images including both intact and ischemic hemispheres, and then 18 F-BCPP-EF data were plotted against rCBF ( Figure 4A ) or rCMRO 2 ( Figure 4B ). The results showed that the regional V T of 18 F-BCPP-EF did not provide a significant correlation with the rCBF (Figure 4A) . In contrast, it should be noted that the regional V T of both 18 F-BCPP-EF was well correlated with the regional rCMRO 2 (R 2 ¼ 0.720, Po0.001) ( Figure 4B) .
At Day-7 after 3-hour MCAO ischemic insult, in addition to the ROI-based analyses described above, ROIs of inflammatory regions (ROI PBR ), defined as areas with 420% increase in 11 C-PBR28 binding in the ipsilateral relative to the contralateral hemisphere ( Figure 5A and red and white colored area in Figure 5F ), were placed on each quantitative image of rCMRglc, rCMRO 2 , 11 C-FMZ, and 18 F-BCPP-EF ( Figures 5B to 5E ). The rCMRglc was significantly higher in the ROI PBR of the right ischemic side than that on the corresponding intact side (Figures 5B and 5I) . In contrast, 18 18 F-BCPP-EF (B), regional cerebral blood flow (rCBF) (C), and regional cerebral metabolism of oxygen (rCMRO 2 ) (D) in the living brain of a monkey (Macaca fascicularis). PET images of 18 F-BCPP-EF (B) were obtained at pre-MCA occlusion ('Normal') and 7 days ('Day-7') postreperfusion after MCA occlusion for 3 hours. PET images of rCBF (C) and rCMRO 2 (D) were obtained at Day-7 only in the same animals as imaged with 18 F-BCPP-EF. 18 F-BCPP-EF, 18 Imaging impaired MC-I in ischemic monkey brain H Tsukada et al ROI PBR of the right ischemic side than on the corresponding intact side. These areas revealed high immunoreactivity to anti-Iba 1 antibody ( Figure 5G ) and low immunoreactivity to anti-NeuN antibody ( Figure 5H ). As shown in Figure 5I , the average rCMRO 2 value decreased from 51.8% in ROI PBR to 34.6% in ROI Infarct (white colored area in Figure 5F ), which was reasonable because the infarct was determined as rCMRO 2 of o40% of intact side. The V T ratio of 18 F-BCPP-EF also decreased from 58.6% in ROI PBR to 41.0% in ROI Infarct , which were well consistent with rCMRO 2 alteration. In addition, 11 C-FMZ showed lower uptake in ROI Infarct than that in ROI PBR . In contrast, the uptakes of 11 C-PBR28 and 18 F-FDG showed similar levels both in ROI PBR and in ROI Infarct .
DISCUSSION
The present results suggest the potential of 18 F-BCPP-EF to be used as a PET probe for the assessment of normal and ischemic impaired MC-I in living brain of nonhuman primate (Macaca fascicularis) using PET. All PET measurements in the present study were conducted under isoflurane anesthetic state, since surgical operation of monkeys for MCAO needed some invasive procedures. 4, 5 We preliminarily evaluated the effects of isoflurane on 18 F-BCPP-EF binding to MC-I by comparing between conscious and anesthetic states in same animals, and concluded that 18 F-BCPP-EF binding was not affected by isoflurane anesthesia in the living brain of monkey (Tsukada et al, unpublished data). Several reports have suggested that general volatile anesthetics (isoflurane, sevoflurane, and halothane) suppress mitochondrial activity through the inhibition of MC-I, in which the mitochondrial membrane potential (DCm) of synaptosomes isolated from rat brain neurons was assessed using fluorescent probes at 1 and 2 minimum alveolar concentration. 25, 26 The parameter of DCm depends on ATP synthesis, Ca 2þ sequestration, and ROS production, 27 and is not an exclusive and direct indicator of MC-I activity. In contrast, 18 F-BCPP-EF used in the present study is a specific PET probe for measuring the MC-I activity in living brain. [6] [7] [8] The dose of isoflurane used in the present study was 0.8 vol.% (0.7 minimum alveolar concentration), which was significantly lower than that used in the previous in vitro studies, 25, 26 and the actual concentration at mitochondria in the brain should be much lower than 0.7 minimum alveolar concentration by considering the metabolism and the distribution in the living body, resulting in no significant effects on MC-I activity in the living brain as measured by 18 F-BCPP-EF.
It has been proposed that an ideal tracer should have high and rapid uptake, rapid washout, followed by reasonably long specific retention in the tissues with the target molecules. 28 From these points of view, the previous [6] [7] [8] and present studies suggested that 18 F-BCPP-EF could be an ideal PET tracer for MC-I imaging because an appropriate lipophilicity of 18 F-BCPP-EF (logD 7.4 ¼ 3.03) 6 could contribute for suitable blood-brain barrier penetration as well as for optimal in vivo specific and nonspecific binding ratios for PET probes. In addition, the moderate affinity of 18 F-BCPP-EF (Ki ¼ 2.31 nmol/L) 6 resulted in reversible-type kinetics with a pseudoequilibrium state of radioactivity within the PET scanning time. [6] [7] [8] The present results showed that the uptake of 18 F-BCPP-EF indicated less rCBF dependence, especially in the regions with luxury perfusion induced after the ischemic neuronal damage in living brain. On the basis of these results, we assumed that K 1 /k 2 was the same in all ROIs to obtain a stable result in the present study.
It was confirmed that the uptake of 18 F-BCPP-EF reflected the specific binding to cellular MC-I, 7, 8 which is the first component of four electron transport complexes in the inner mitochondrial membrane. By in vitro assay in rat brain slice, 18 F-BCPP-EF binding was inhibited by rotenone, a specific MC-I inhibitor, in a dosedependent manner. 7 Furthermore, by in vivo assay in rat using small animal PET, although dose escalation study was impossible because of the lethal effects of rotenone on cardiac function, the significant reduction in uptake into the brain as well as into the heart was observed even at a relatively low dose of 0.1 mg/kg per hour. 7,8 18 F-fluoro-2-deoxy-D-glucose is useful with easier operation compared with rCBF and rCMRO 2 measurements with three consecutive measurements using very short half-life 15 O-gases. However, as shown in the present study, higher accumulation of 18 F-FDG occurred in both ROI PBR and ROI Infarct than on the The uptake values in each ROI were normalized to 1 GBq injection dose and 5 kg body weight. TAC data in the brain regions and blood expressed as mean values, and those in metabolic profiles as mean±s.d. for seven animals. 18 F-BCPP-EF, 18 
corresponding intact side at Day-7/8 after 3-hour MCAO ischemic insult. Immunohistological study with anti-Iba 1 and anti-NeuN antibodies evidenced that the high 18 F-FDG uptake could be attributable to the accumulation of activated microglial cells in ROI PBR and ROI Infarct . The higher degrees of 18 F-FDG as well as 11 C-PBR28 were almost similar in both ROI PBR and ROI Infarct in the present study. The previous reports regarding the relationship between neuronal damage and inflammation indicated controversial results. Some reports showed the increase in 11 C-PK-11195 binding in peri-infarct regions, but not in infarct region, at Day-7 in rat ischemic model. 9, 10 Another report reported no significant changes in 11 C-PK-11195 binding in either peri-infarct or infarct regions at Day-9, similarly increase in both regions Day-21 and later in baboon ischemic model, while 11 C-FMZ binding was significantly reduced from Day-2 and later. 29 Take together, the relationship between neuronal damage and inflammation might be altered depending on the species, models and timing after ischemic insult.
In developed cells like neurons, glucose is converted into pyruvate through a tricarboxcylic acid cycle and ultimately produces energy via the electron transport system and oxidative phosphorylation, accounting for ca. 85% to 90% of the glucose used in the adult humans. 30 In contrast, activated inflammatory cells, such as macrophages and microglia, produce lactate from glucose, known as the Warburg effect 31 or aerobic glycolysis, accounting for only ca. 5% glucose utilization in oxidative phosphorylation. [30] [31] [32] [33] [34] For rCMRglc analyses in this study, we applied a fixed lumped constant of 0.56, 23 which is a correction factor to convert FDG metabolic rate into rCMRglc determined from normal human brains. Since a previous study suggested that rCMRglc calculated with a fixed lumped constant would be underestimated at high metabolic rates and overestimated at low metabolic rates, 35 the rCMRglc in inflammatory (ROI PBR ) and infarct (ROI Infarct ) regions might be underestimated and overestimated. Since recent PET research indicated that several neurodegenerative disorders showed neuroinflammation with microglial activation, 11 based on the metabolic differences between normal neuron cells and activated microglial cells, it could be assumed that MC-I-specific PET probes like 18 F-BCPP-EF would be useful as more accurate indicators of neurodegeneration in living brain.
The present results showed that the ischemic-induced infarct areas (ROI Infarct ), determined as region with rCMRO 2 of o40% of intact side at Day-7 as previously reported, 24 showed much lower V T of 18 F-BCPP-EF than that in ROI PBR . In addition to the inclusion of ROI Infarct in ROI PBR , this result could suggest that inflammatory region includes infarct and peri-infarct regions, which region might be curable remaining high rCMRO 2 . In these hyperperfused areas, decreased rCMRO 2 was observed thereafter, suggesting that reperfusion-related ROS production may in part contribute to neuronal damage of reperfusion injury. Mitochondria are considered the main intracellular source of ROS and also the main target of oxyradical-mediated damage. Since MC-I exhibits lower activity compared with the other respiratory chain complexes, it is a limiting factor in the regulation of oxidative phosphorylation. The decrease in the MC-I activity induced in ischemic/reperfused brain should be associated with a decline in mitochondrial respiration. These factors could reasonably explain the present result of a good correlation between V T of 18 F-BCPP-EF and rCMRO 2 , which is a conventional indicator of mitochondrial respiration.
It has been reported that ischemic insult induces the diaschisis which is defined as a depression of regional blood flow and metabolism caused by dysfunction in an anatomically separate but functionally related neuronal region, however, may not reflect neuronal death. 36 The present study showed that the V T of 18 F-BCPP-EF was not related to rCBF in the brain ( Figure 4A ), and also that the V T of 18 F-BCPP-EF was not affected by inflammation ( Figures 5E and 5G ) that caused high rCMRglc ( Figures 5B and 5I ). In addition, the decreased V T of 18 F-BCPP-EF was observed in the regions with low immunoreactivity to anti-NeuN antibody ( Figures  5E and 5H) . Take together, although further studies should be needed, the MC-I imaging using 18 F-BCPP-EF might be useful to discriminate diaschisis and neuronal death.
In the present study, 11 C-FMZ-PET was also conducted to assess the neural damage in ischemic regions, since CBR was considered to be a superior method for accurate detection of ischemic cerebral damage in primates. 29, 37, 38 However, since the CBR is exclusively located in the cortex, not in the white matter and basal ganglia, 11 C-FMZ can detect the neuronal damage in the cortex. In contrast, 18 F-BCPP-EF can image to detect the neuronal damage in whole brain. In addition, the present study showed less 11 C-FMZ binding to CBR at Day-7 after 3-hour MCAO cortical ischemic insult than rCMRO 2 and 18 F-BCPP-EF binding. It was reported that there were no significant changes in the in vitro 3 H-FMZ binding to CBR in rat brain in the acute phase after 3-hour MCAO cortical ischemic insult. 39 We recently reported a relatively slow temporal change in the rat brain uptake of 11 C-FMZ after focal cerebral ischemia after photochemically induced thrombosis. 9 In addition, 3 H-FMZ binding in vivo was relatively insensitive to cell death induced by sodium nitroprusside, a traditional NO donor compound. 40 These three previous studies and the present data suggest that FMZ binding to CBR might be considerably more stable against cell death, and providing more time to detect neuronal damage in the brain. . Effects of inflammation with accumulation of activated microglia on 11 C-PBR28 binding (A), regional cerebral metabolic rate of glucose (rCMRglc) (B), regional cerebral metabolism of oxygen (rCMRO 2 ) (C), 11 C-flumazenil ( 11 C-FMZ) binding (D), and 18 F-BCPP-EF binding (E). Regions of interest (ROIs) of inflammatory (ROI PBR ) and infarct (ROI Infarct ) regions at Day-7 (F) were placed on each quantitative image of rCMRglc, 11 C-FMZ, rCMRO 2 , and 18 F-BCPP-EF, and the ischemic/intact ratios were calculated for each probe (I). Data are expressed as mean±s.d. for seven animals; # Po0.05, *Po0.01 (G). After positron emission tomography (PET) imaging, monkey brains were dissected for immunohistological analyses with anti-Iba 1 (G) and anti-NeuN (H) antibodies. 18 F-BCPP-EF, 18 One limitation of the present study was that MR imaging could not be conducted after ischemic insult to detect anatomic and pathologic changes because of the Japanese low as described in Materials and methods. If MR imaging data after ischemic insult were coregistered with PET data presented here, then the deeper insight might be obtained for changes in MC-I activity.
In conclusion, the present study succeeded to validate 18 F-BCPP-EF, a novel PET probe for MC-I activity, as a specific marker of ischemia-induced neuronal death without being disturbed by inflammation.
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